A major discovery in cancer study is emerging with the use of VHH fragments to reactivate dysfunctional p53. This crucial cancer inhibitor protein is frequently lost in many kinds of malignancies, causing uncontrolled https://pr6bookmark.com/story22159797/mini-antibodies-revive-tumor-suppressor-p53-a-new-pathway-for-cancer-therapy